HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kate C Gillespie Selected Research

Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

12/2017Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kate C Gillespie Research Topics

Disease

1Neoplasms (Cancer)
12/2017
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2017

Drug/Important Bio-Agent (IBA)

1voruciclibIBA
12/2017
1venetoclaxIBA
12/2017

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2017
1Therapeutics
12/2017
1Precision Medicine
12/2017